Gene Transfer for Patients With Sickle Cell Disease

Clinical trial NCT02186418 · TERMINATED

Trial details

NCT number: NCT02186418
Sponsor: Children's Hospital Medical Center, Cincinnati
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Anemia, Sickle Cell

Start date: 2014-07-01
Primary completion: 2022-10-31
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.